Paulsen is the owner and chairman of Ferring, a drugmaker that specializes in medicines for reproductive medicine and women's health. The Saint-Prex, Switzerland-based company's products include fertility treatments Menopur and Rekovelle. Ferring has annual revenue of approximately $2.4 billion.
Frederik Paulsen's net worth of $5.24B can buy ...
... and is equivalent to ...
Paulsen is the majority owner of Ferring Pharmaceuticals, the drugmaker founded by his father in 1950. He controls his stake through Insula, a British Virgin Islands-based holding company. Ferring had revenue of approximately $2.4 billion in 2017, according to company spokeswoman Lindsey Rodger. The closely held business doesn't disclose detailed financial results.
The business is valued using the average enterprise value-to-sales multiple of three publicly traded peer companies: H Lundbeck, Ipsen and Endo.
Paulsen didn't respond to e-mail and telephone messages requesting comment on his net worth.
Frederik Paulsen was born in 1950 in Malmo, Sweden, the same year his father founded Nordiska Hormon Laboratoriet. The company was renamed Ferring four years later. Paulsen studied chemistry at the Christian-Albrechts-University in Kiel, Germany, and business administration at the University of Lund in Sweden.
He started work at Ferring in 1976, heading its Swedish division seven years later, and becoming chief executive officer of the group in 1988. He transferred Ferring's headquarters to Saint-Prex from Malmo in 2006 and today is the company's chairman.
The billionaire also is an explorer and spends much of his time planning and participating in scientific trips, including a trip to the Arctic seabed in 2007. He is married and has three children.